H
Harpago CDMO specializes in formulation design to enhance the solubility of poorly water-soluble small molecule therapeutics. The company offers expertise across various technologies, including amorphous solid dispersions, nanosuspensions, and lipid-based formulations. This focused approach supports clients from preformulation through clinical trial manufacturing to unlock therapeutic compound potential.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Harpago CDMO specializes in formulation design to enhance the solubility of poorly water-soluble small molecule therapeutics. The company offers expertise across various technologies, including amorphous solid dispersions, nanosuspensions, and lipid-based formulations. This focused approach supports clients from preformulation through clinical trial manufacturing to unlock therapeutic compound potential.